Flow control equipment manufacturer Flowserve (NYSE: FLS) missed Wall Street’s revenue expectations in Q4 CY2025 as sales rose 4.6% year on year to $1.24 billion. Its non-GAAP profit of $1.11 per share was 18.4% above analysts’ consensus estimates.

Is now the time to buy FLS? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Flowserve’s fourth quarter performance garnered a positive market reaction, as the company reported continued momentum in its aftermarket segment and highlighted progress on operational improvements. Management credited strong aftermarket bookings and growth in power and nuclear end markets as key drivers, while original equipment sales faced temporary delays due to customer and material timing issues. CEO Robert Rowe emphasized the resilience added by the company’s diversified portfolio and noted, “Our 3D diversification strategy has made Flowserve more cycle-resilient than ever before.”

Looking ahead, Flowserve’s guidance is shaped by anticipated growth in nuclear and power markets, supported by recent acquisitions and operational initiatives. Management expects aftermarket strength to persist and original equipment activity to accelerate in the second half of the year, with Trillium Valves broadening content opportunities. CFO Amy Schwetz stated, “We expect continued growth and operating margin expansion from higher sales and further cost reductions through 80/20 portfolio refinement.” The company’s focus remains on leveraging operational excellence, supply chain agility, and targeted M&A to drive sustained profitability.

Key Insights from Management’s Remarks

Management attributed the latest quarter’s results to robust aftermarket demand, operational improvements, and expanding exposure in nuclear and power markets, while project-related delays weighed on original equipment sales.

• Aftermarket momentum: The aftermarket business saw its seventh consecutive quarter of bookings above $600 million, with management attributing growth to a large installed base and enhanced capture rates. This segment’s rapid revenue conversion is helping offset sluggish original equipment activity.
• Operational excellence initiatives: Margin improvements were driven by ongoing execution of the Flowserve Business System, including complexity reduction via the 80/20 program and targeted cost controls. Schwetz highlighted a 320 basis point gross margin improvement year-on-year as evidence of these initiatives' impact.
• Nuclear and power segment expansion: Awards in nuclear and traditional power markets contributed significantly to bookings, with Flowserve’s leadership noting over $100 million in nuclear bookings and the acquisition of Trillium Valves expanding available content per reactor by 15–20%.
• M&A integration success: The integration of Mogas and the planned addition of Trillium Valves are seen as proof points for Flowserve’s disciplined M&A strategy. Management cited operational and margin benefits from the Mogas integration and expects similar outcomes with Trillium.
• Supply chain agility and tariff management: The company successfully mitigated tariff impacts through strategic sourcing changes and pricing actions, demonstrating adaptability in a volatile global trade environment.

Drivers of Future Performance

Flowserve’s outlook is anchored by expectations for continued aftermarket strength, increasing nuclear and power project activity, and margin expansions through operational initiatives.

• Nuclear and power growth: Management anticipates outsized growth in nuclear and traditional power markets, with recent acquisitions like Trillium Valves positioning Flowserve to capture higher content per new reactor and benefit from global investments in energy infrastructure.
• Operational discipline and margin focus: The 80/20 program and Flowserve Business System are expected to drive further manufacturing efficiency and margin expansion, even if revenue growth is muted in the near term. Management believes these structural improvements can sustain double-digit EPS growth through 2030.
• Backlog conversion and project timing: The mix of longer-term nuclear projects in the backlog is expected to moderate near-term revenue growth but provide a tailwind in subsequent years. Management noted that only 76% of the backlog will convert to revenue in the next 12 months, shifting earnings cadence toward the latter half of the year.

Catalysts in Upcoming Quarters

In upcoming quarters, our analysts will watch (1) the pace at which Flowserve converts its record nuclear and power backlog into revenue, (2) the sustainability of aftermarket growth and its margin contribution, and (3) the effectiveness of Trillium Valves integration in expanding the company’s presence in high-margin sectors. Execution on operational efficiency and the ability to navigate ongoing supply chain and tariff challenges will also be key factors.

Flowserve currently trades at $85.40, up from $78.98 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).

High Quality Stocks for All Market Conditions

The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.